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Abstract
Objective—To characterize practices in subspecialist physicians’ communication styles, and
their potential effects on shared decision-making, in second-opinion consultations.
Methods—Theme-oriented discourse analysis of 20 second-opinion consultations with
subspecialist hematologist-oncologists.
Results—Physicians frequently “broadcasted” information about the disease, treatment options,
relevant research, and prognostic information in extended, often-uninterrupted monologues. Their
communicative styles had one of two implications: conveying options without offering specific
recommendations, or recommending one without incorporating patients’ goals and values into the
decision. Some physicians, however, used techniques that encouraged patient participation.
Conclusions—Broadcasting may be a suboptimal method of conveying complex treatment
information in order to support shared decision-making. Interventions could teach techniques that
encourage patient participation.
Practice Implications—Techniques such as open-ended questions, affirmations of patients’
expressions, and pauses to check for patient understanding can mitigate the effects of broadcasting
and could be used to promote shared decision-making in information-dense subspecialist
consultations.
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1. Introduction
In the face of complex disease, physicians and patients struggle to make the “best” treatment
decisions; that is, decisions most consistent with the patient’s goals for care. This is
particularly true for patients with hematological malignancies, many of whom are
considering hematopoietic cell transplantation (HCT). These transplantations have wide
variations in intensity; however, all involve a substantial amount of risk and invasiveness
without the guarantee of a cure. Decisions on HCT, like many in the subspecialist setting,
are highly sensitive to patient preferences [1]. Yet communication in subspecialist
encounters remains relatively understudied. What is known is that although cancer patients
vary in the level they want to be involved in the decision-making process, many do want to
be involved [2]. Additionally, physicians and patients can experience conflict over treatment
decisions [3]. Given the complexity of shared decision-making in these conversations,
knowing how they occur could inform interventions aimed at improving them. However,
little is known about the actual interactional dynamics of these subspecialist consultations.
Thus, in this study, we sought to explore practices in subspecialist communication that may
influence shared decision-making by examining encounters between patients with
hematological malignancies and subspecialist hematologists.
2. Methods
2.1 Data collection
The physician-patient encounter transcripts in this analysis came from HEMA-COMM, a
study of audio-recorded consultations between 236 patients and 40 hematologists at the
Dana-Farber Cancer Institute (Boston, MA) and Fred Hutchinson Cancer Research Center
(Seattle, WA) between 2003–2007. Their median duration was approximately 69 minutes
[4]. The study was approved by the institutional review boards of both participating
hospitals.
From this larger sample, 20 patients were purposively selected for further analysis (Table 1).
They were chosen to reflect a diverse set of cancers, age ranges, and estimated prognoses, as
well as relative balance in race and education. Fifteen physicians were represented in this
sample. This manuscript reports on a qualitative analysis of the 20 audio-recorded
consultation visits from this sample.
2.2 Data analysis
We used theme-oriented discourse analysis methods [5–7] to study how physicians’
language choices affect the potential for shared decision-making. Unlike other approaches
that only allow consideration of what is spoken, discourse analysis emphasizes prior
ethnographic knowledge of the context as a whole [6]. Because the parties in a subspecialty
consultation carry a substantial set of expectations and assumptions, we believed such a
methodology was necessary.
We read each consultation transcript in close detail, first with an “unmotivated,” inductive
approach. As patterns emerged, we re-read each consultation transcript and annotated
examples of each pattern, along with markers of power or control, such as turn-taking,
question-taking, and topic control [7] as well as patients’ expressions of emotion and
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treatment preference. Consultations with similar physician-patient relationships were re-read
side-by-side, to assess patients’ responses to certain physician behaviors and to isolate
common linguistic features. Next, we compared our annotations of each consultation with
the patients’ reactions to them as articulated in their qualitative interviews.
This analysis differs from others based on the HEMA-COMM dataset [4, 8, 9]. A 2009
paper [4] qualitatively analyzed patients’ reactions to their consultations based on separate
interviews conducted with each patient. That paper focused on patients’ reactions to their
physicians’ communication style but did not simultaneously assess the physician’s
communication style. A 2011 paper identified demographic predictors of advance care
planning among patients with hematologic malignancies, but did not address communication
in their consultations [8]. A 2012 paper [9] “counted” the frequency of certain recommended
communication practices, and used multiple regression models to identify predictors of
those practices. By focusing on “counts,” however, it did not elaborate on the language used
in each consultation. The present analysis, by contrast, deals explicitly with the language
used by subspecialist physicians in each encounter to describe in detail the communicative
behaviors of physicians and their immediate effects within the consultation.
3. Results
3. 1 Broadcasting
The most ubiquitous finding was a pattern of lengthy physician monologues on disease
mechanisms and history, treatment options, or prognostic information. We termed this
pattern “broadcasting.” A representative excerpt of a “broadcast” can be found in Table 2.
The most striking feature of the broadcast is its length: physicians occasionally spoke
uninterrupted for ten minutes or longer, leaving very little time for patients to process
information or ask questions before moving on to new topics. For example, throughout the
excerpt in Table 2, the physician does not stop to allow the patient to speak. He outlines four
different treatment options, but does not pause to ask the patient if she understood each of
them. Throughout the dataset, there was some variation in how often physicians stopped and
allowed patients to participate and in the length of the broadcast. Out of the 20 consultations,
17 (85%) had an uninterrupted physician monologue at least 20 lines in length (the
broadcast in Table 2 is 28 lines, each about 17 words), 10 (50%) had one lasting at least 30
lines, and 6 (30%) had one lasting at least 40 lines. Continuers or minimal utterances
(“right,” “mhm,” etc.) were not interpreted as terminating the broadcast.
However, duration of uninterrupted speech is not the only defining feature of a broadcast.
Intended topic control is also characteristic. Physicians did stop for interruptions, but often
returned to the broadcast immediately after responding to the patient. Interruptions (by
definition) were not invited by the physician. Once interruptions were answered, topic
control remained with the physician.
In the Table 2 excerpt, the physician outlines treatment options in the order that they were
developed. Apart from HCT, the physician says that the standard of care for chronic
myelogenous leukemia progressed from hydroxyurea, to interferon, to Gleevec, and then
explained how Gleevec was discovered in some detail. This “historical” format appeared
frequently in our dataset.
Less common was this physician’s act of individualizing each treatment option in terms of
its appropriateness for the patient. Unlike many studied, this physician articulated his
rationale for recommending against bone marrow transplantation, hydroxyurea, and
interferon based on the unique characteristics of his patient.
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Unlike the physician in Table 2, many physicians did not evaluate each treatment on behalf
of the patient. Instead, they used language that minimized their role in the patient’s decision
and deferred to the patient’s autonomy. In this example, a physician is discussing the choice
between Gleevec and HCT:
Physician: There’s some patients who hear about the Gleevec and hear about the
transplant stuff and say you know, I’m not going to do the transplant until I have to
in the extreme. But there are actually some people who say I’m not going to…
This physician emphasizes that “some patients” choose each approach, presumably to
illustrate that either would be a good decision. By referring to hypothetical patients,
however, the physician does not apply his knowledge to the particulars of this patient’s case
or guide the patient with a specific recommendation.
Another related pattern was physicians’ use of the second person “you” (note underlined
language):
Physician: or if you really sort of feel like you didn’t want to be in a clinical trial,
we are ok with that if you don’t want to be in the clinical trial. … if you are
particular interested in pursuing the [inaudible] mini-transplant then you need to
figure out if your brother matches you. Kind of you have to decide I think when
you leave here if that is a viable option that you want to pursue and in which case
then our next step would be get your brother’s blood and your blood and type you
two.
By saying “you need to figure out” the treatment course, this physician, like several others,
repeatedly emphasizes the patient’s agency relative to his own. He uses the “we” form when
he says “our next step,” but this step is contingent on the patient (“you”) deciding on a mini-
transplant. Passage 2 shows a significantly different stance from that of Table 2, in which
the physician says “I’ll probably decide on a bone marrow transplant,” implying that the
decision is his own rather than the patient’s.
3.3 “Directive” Language
In Table 2 and in other consultations, physicians communicated in ways that implied that
they are conveying the right decision—the opposite of “deferential” language.
Physician: Some of the new treatments for myeloma are, um, combining
Decadron, which I just mentioned to you, with thalidomide, orally, which is very
effective and will get rid of a lot of protein. Or, the other one is called Velcade…
So, the only thing that I would mention to you is that the Velcade and the
thalidomide, although I think they are terrific, … the Decadron does not cause
neuropathy. OK, the thalidomide and the Velcade both cause neuropathy. So for
someone who has a bad neuropathy … I would probably vote with starting first
with just Decadron alone … Let’s say four days in a row, maybe, why don’t we do
the 4 days on 4 days off, 4 days on 4 days off, 4 days on 4 days off, 12 days a
month. Cause we, for a couple of months, that’s pretty aggressive. But that’s really
trying to get you out of trouble, okay?
Patient: Yes, cause I gotta get out of trouble.
Here, the physician explains that Decadron, Velcade, and/or thalidomide are all good
treatments for myeloma, but given the patient’s neuropathy, he would favor an aggressive
treatment of Decadron alone. Note the contrast between his language (“I would vote”) and
that of Passage 2 (“you have to decide”). He places more emphasis on his agency than the
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patient’s. Without pausing after explaining the risks of Velcade and thalidomide, he
immediately begins to outline an aggressive regimen of Decadron alone. And when he cedes
the floor to the patient, it is not for the patient to ask about alternative treatment options.
Rather, his question (“that’s really trying to get you out of trouble, okay?”) serves to confirm
that the patient understands his rationale before explaining further details of his Decadron
treatment plan.
The excerpt in Table 2 exhibits similar features. The physician does not turn the
conversation to the patient while other treatments (bone marrow transplantation,
hydroxyurea, interferon) are still options. Rather, he delves straight into the results he has
observed with Gleevec. He does so without allowing the patient to ask more about the
alternative treatments. Additionally, as discussed in Section 3.2, his pronoun choice is
significant: “I’ll probably decide on doing a bone marrow transplant” rather than “you
could,” or something similar.
3.4 “Inviting” Language
Several physician communication behaviors appeared to encourage patient participation in
the consultation. For example, this exchange has a markedly different pattern from the
“broadcast” in Table 2:
Physician: I’ll be very happy to help you with that. Ok. Now, um, [Patient], in
terms of treatment, what have you been told so far about what would be the next
steps?
Patient: Well, I was told that most probably it will be chemotherapy of some kind,
that there are several different um drugs that can be used.
Physician: Right.
Patient: That the major differences between them would probably be the length of
remission that we might have.
Physician: Yes.
Rather than describing the next steps himself, this physician allows the patient to tell him
what she knows with an open-ended question. In addition, rather than cutting the patient off,
he uses affirmations like “right” and “yes” to encourage her to continue her response. This
may limit the amount of information the physician later needs to deliver.
Another excerpt illustrates yet another way that some physicians encouraged their patients to
participate in the conversation:
Physician: So it works both ways, because the incoming donor cells, so we want to
get the donor cells to engraft … to be accepted, into your body and replace your
immune system, so as it’s doing that we don’t want it to attack your body too
strongly.
Patient: Right
Physician: And if the host cells, if your body kicks out the incoming donor cells,
then you’re rejecting the graft, but if the donor cells attack your body too strongly,
that is called graft versus host disease.
Patient: Oh I’ve heard of that
Physician: The donor cells, the graft cells, versus you the host.
Patient: Right, that’s the point that that happens
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Physician: Yeah… after the transplant has happened, engrafted, after the donor
cells take, and are engrafted.
Patient: Right.
This physician appears to encourage a response, however brief, after each item of
information—implicitly inviting the patient to confirm that her understanding. This may be
the result of pausing, altering intonation, or some other combination of interactional cues.
From this excerpt, one can see that the physician need not ask the patient to confirm her
understanding after each sentence—she does so on her own, presumably invited by some
aspect of the physician’s speech. The patient also does not use those cues to take over the
conversation; the physician continues his explanation without veering off topic. This style of
encouraged participation differs significantly from the “broadcast” where the patient would
have to interrupt to show understanding or ask questions.
4. Discussion and Conclusion
4.1 Discussion
This analysis revealed how certain subspecialist communicative behaviors may influence the
potential for shared decision-making between the patient and physician. The first and most
salient feature was most physicians’ tendency to “broadcast” information in extended
monologues. These monologues were characterized by remarkable length, unilateral topic
control, and patterns of information delivery that varied little from patient to patient. The
research team coined the term “broadcasting” to emphasize its unilateral, uniform nature—
relying little on patient feedback and appearing rehearsed rather than individualized. Though
communication styles varied, broadcasting was virtually ubiquitous. The purpose of these
subspecialist consultations was, of course, to provide patients with information and
treatment options. So broadcasting may have been a well-intentioned way to convey as
much information as possible in a finite time period.
However, 40–80% of medical information is forgotten immediately after a consultation [10].
Mentioning certain information in the course of a broadcast does not ensure that the patient
will understand or retain it. Additionally, an increased proportion of physician speech
(relative to the family’s) has been linked to decreased family satisfaction in the critical care
setting [11]. In many of our cases, the sheer amount of information delivered visibly
increased patients’ anxiety levels as well, causing overt statements of fear, confusion, or
distress.
In addition, the typical organization of these broadcasts may not be the optimal way to
present choices to a patient. Our data showed a tendency for physicians to describe treatment
options all at once, often in a “historical” sequence mirroring the order in which each option
was developed. While it may be natural for a physician-researcher who has seen each option
develop, it has little relation to the relative risks and rewards of each option. An approach
that discusses treatment options sequentially, according to their risk/reward ratio, has been
proposed to better explain the tradeoffs of each option [12].
Broadcasts had no specific position in the sequence of the consultation, and were used for a
variety of purposes. They typically dealt with treatment options in some way, in keeping
with the goals of the subspecialist consultation, but the specific content varied. The
“historical” approach mentioned before was common, but some physicians used broadcasts
to explain disease biology, propose a treatment course, or to share the prognosis associated
with each treatment option. At the close of the broadcast, the consultation continued in
briefer turns with a larger role for patient input. Physicians and patients found agreement on
intermediate steps, such as human lymphocyte antigen (HLA) testing or a follow-up
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conversation with the referring oncologist. However, in the majority of consultations, a
definitive decision to pursue treatment with the subspecialist was not made.
As shown in Section 3.4, certain practices broke up the rhythm of broadcasting and
“invited” patients to participate more. Open-ended questions assessed patients’ prior
knowledge to focus information delivery. Affirmations and periodic pauses also encouraged
patients to enter the conversation. These behaviors are particularly important when facing
patients less confident in their ability to communicate with the physician [13]. Of course,
physicians “invite” patient speech routinely as they obtain the patient’s history. However,
such invitations were considered relevant to this study because they do not enhance the
patient’s role in decision-making; history-taking is part of even the most physician-
dominated conversations. In this study, we highlighted physician practices that allowed the
patient to participate in information delivery and decision-making.
We observed two patterns that appeared to reflect the physician’s desired role in decision-
making: deferential and directive language. These types of speech were not restricted to
broadcasts, occurring even in rapid exchanges when treatment options were being discussed.
However, if one pattern predominated in a broadcast, it typically characterized the
remainder of the consultation as well. Deferential strategies helped physicians lay treatment
options out neutrally, but physician neutrality appears inadequate as treatment options
multiply and the complexity of tradeoffs increases [2, 14, 15] [15]—both of which are
particularly true in subspecialty consultations.
By contrast, “directive” language allowed physicians to assert their opinions in the decision-
making process. It was characterized by use of the first person (“I’ll vote for”), and often an
explicit mention of the patient characteristics that led to that recommendation; together,
these suggest that the physician’s recommendation is the only right choice. As in Passage 3,
physicians occasionally issued strong recommendations (“Decadron alone”) eventually
followed by language deferring to the patient (“that’s trying to get you out of trouble,
okay?”). The question may serve to hedge the directive recommendation, but its format still
implied that the recommendation was the best option. Such hedges did not appear to change
the generally directive nature of the consultation as a whole. That is, though a physician may
use deferential language to hedge directive comments, the overall tone of the consultation
remained directive.
Of course, it is safe to assume that physicians have their patients’ best interests at heart when
they make a recommendation. And in many cases, the treatment choices may be obvious.
However, according to past research, directive strategies make it increasingly difficult for
patients to disagree without threatening the physician’s authority [16–18]. Consider how in
Passage 3, the patient does not articulate that she has chosen Decadron over the other
options, but merely that she assents to the physician’s reasoning (“Yes, cause I gotta get out
of trouble”). Past research on similar exchanges has concluded that patients often do not
understand they have a choice to make. Instead, such responses reflect assent rather than
consent, which is not equivalent to informed choice [19].
The difference between assent and informed consent is subtle, but critical. Patients’ fear of
appearing “difficult” makes them significantly less likely to challenge a physician’s
recommendations and achieve shared decision-making [20]. This is not to say that
physicians’ recommendations are inherently coercive or problematic—patients often want
personalized recommendations from their physicians [2, 4, 14]. But these findings
underscore two needs: first, for physicians to understand their patients’ decision-making
preferences at the outset of a consultation, and second, for them to be acutely sensitive to the
fact that their patients may be reluctant to challenge their authority. Since directive language
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is likely to exacerbate such reluctance, physicians seeking to encourage patient participation
should use such language with care. Conversely, if patients reveal that they would prefer the
physician to make an explicit treatment recommendation, physicians should monitor their
use of deferential language.
Our study had several limitations. First, the consultations came only from two sites and 15
physicians. The observations may have been specific to those sources. Second, we lacked an
objective method of assessing patient reactions to communication behaviors in the moment.
That is, we were not able to judge patients’ satisfaction, distress, or understanding of
information in real-time. Instead, we relied on patients’ verbal responses to their physicians’
communicative behaviors. Third, it is possible that physicians’ communicative behaviors
depended entirely on what was available—that, for example, physicians only took directive
approaches when there was just one suitable option, and always took distancing approaches
when there were multiple. However, the fact that physicians mentioned multiple treatment
approaches even when using directive language suggests that this was not the case.
4.2 Conclusions
We observed a variety of communication styles, but many conversations shared the use of
lengthy physician “broadcasts” to explain disease mechanisms, treatment options, or
prognostic information. Given past research on information retention, risk communication,
and patient satisfaction [10–12] as well as our observations of patient responses,
broadcasting may be a suboptimal way of conveying complex treatment information in the
subspecialist encounter. However, we documented several communication behaviors that
appeared to promote patient participation and could be used by physicians to prompt their
patients to articulate themselves. We also captured examples of language that encourages
patients to make decisions independently, as well as language that supports a more dominant
physician role in decision-making. We argue that neither is a priori preferable, but rather
should be matched to patients’ preferences and characteristics as well as the physician’s
communicative aims. This paper took an exploratory, inductive approach to identifying
themes in subspecialist communication. Future studies should examine these themes
explicitly, with patient-centered outcomes (information comprehension, satisfaction,
distress, etc.) and objective measures of shared decision-making as endpoints.
4.3 Practice Implications
Our results offer typical examples of the various communication behaviors used by
subspecialists in first-time consultations. They support past research demonstrating the
heterogeneity of physicians’ orientations toward shared decision-making [14, 21], but more
importantly, they show how styles manifest in actual encounters. Broadcasting may help
physicians establish credibility and give a general overview of relevant information, both
important objectives of an initial visit, but it may be an ineffective means of patient
education [4, 10–12]. Inviting behaviors are ways to facilitate patient participation in the
encounter as well as to explore patients’ values and goals for treatment. Deferential and
directive speech have both strengths and weaknesses, but styles should be chosen carefully,
with a regard for the patient’s preference in decision-making and the presence (or absence)
of equipoise [15, 21, 22].
Since these examples bridge the gap between archetypes of physician style and real-life talk,
they may be valuable as heuristics for clinicians and researchers assessing communication
style. Clinicians may be able to identify commonalities between their communication
behaviors and those outlined in this paper. Finally, though subspecialist consultations are
unique in many ways, information delivery constitutes a great share of physician-patient
communication. Because the themes of this paper revolve around communicating treatment
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options, these findings could extend to any medical context in which preference-sensitive
decision-making plays an important role.
I confirm all patient/personal identifiers have been removed or disguised so the patient/
person(s) described are not identifiable and cannot be identified through the details of the
story.
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• Explores practices in subspecialist physicians’ communication styles, with
regard to shared decision-making
• Hematologists delivered information in lengthy “broadcasts,” which may be
suboptimal for sharing complex decision-making
• “Deferential” language emphasized patient autonomy and minimized the
physician’s role in the decision
• “Directive” language focused on the physician’s recommendation, excluding
alternative treatment options
• Certain communicative behaviors encourage patient participation and may
promote shared decision-making
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Table 1
Participant Characteristics
Patients [n=20] N (%) Physicians [n=15] N (%)
Gender Gender
Male 8 (40%) Male 13 (85%)
Female 12 (60%) Female 2 (15%)
Disease Age
Acute leukemia 6 (30%) 30–39 3 (20%)
Chronic leukemia 3 (15%) 40–49 5 (33%)
Multiple myeloma 6 (30%) 50–59 6 (40%)
Lymphoma 2 (10%) 60–69 1 (7%)
Myelodysplastic syndrome 2 (10%)










American Indian/Asian/Pacific Islander 3 (15%)
Education
Less than college 2 (10%)
Some college/college degree 12 (60%)
Postgraduate degree 6 (30%)
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Table 2
Representative Excerpt of a Physician “Broadcast”
Physician:
 [If] a 25 year old comes in, with your condition, the same CML in stable phase and has a sibling that matches, you know, I’ll probably decide
on doing a bone marrow transplant. Knowing there is a risk of this transplant, but if you do well with the transplant, it’s a good chance that
you’re cured. However, for people who are older and who have medical conditions, you know, for example, in your case the colon cancer and
other issues, um, those kind of transplants might be a bit too risky. In a person whose age is over 40 or 50, the risk of dying from the transplant
itself is fairly high and therefore we have not been pushing for patients, at this age, to all get transplants.
 So what’s the alternative to transplantation, is the next question. So, in the past, there hadn’t been any very good treatments for this disease.
People have used a drug called Hydrea to control the counts, Hydroxyurea, it’s a pill you take once a day. That controls your white blood cell
counts but it does not delay the progression of the disease and does not change survival. The only drug in the past that has impacted on survival
is a drug called interferon. … The problem with interferon is that it is a terrible drug. People get very depressed on it, people get lots of flu like
symptoms, so, you know, based on what you are telling me now, I think interferon would be a very bad drug for you, just because of the
depression issues, the fibromyalgia issues. Furthermore interferon is not all that effective. It maybe about 15% will achieve what they call a
cytogenetic remission; you see that the chromosome goes away, the Philadelphia chromosome…
 Well the exciting thing is then, there’s this drug called Gleevec. It’s obviously a recent development. Gleevec has been approved only a
couple of years ago, 3 or 4 years ago. And the way Gleevec works, is that, Gleevec is actually the first drug, what we call a rationally designed
drug. … As I told you, this disease, it’s the hallmark of the disease, is this translocation, where you have this break between chromosome 9 and
chromosome 22. It makes this new Gene called the BCR-ABL gene. Well, since we’ve been able to clone this gene, they actually make this
thing in the laboratory, you can actually test things that can block it. Well one of the researchers … was interested in seeing if he could find
chemicals that specifically block this gene. … And after going through an exhaustive search, they’ve isolate one, in particular, that seems to be
very effective in blocking the action of this gene. … And so, you know, basically, it’s very basically a design drug.
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